Riskpilot← Back to searchSign inGet full accessPHARMAVIE A/S
A/SActiveCVR 26553148Korskildelund 4, 1.Business and other management consultancy activities · NACE 7020Est. 20021 employees
Revenue 2025
DKK 173K
-58% vs 2024
EBITDA margin
16.5%
-88% vs 2024
Equity ratio
-10.7%
Financial strength
Net profit 2025
DKK 821K
-49% vs 2024
| Revenue | DKK 173K | -58% |
| EBITDA | DKK 29K | -88% |
| Net profit | DKK 821K | -49% |
| Total assets | DKK 9,2M | -14% |
| Equity | DKK -979K | +46% |
| Employees | 1 | — |
Legal name
PHARMAVIE A/S
CVR number
26553148
Legal form
Aktieselskab
NACE code
7020 · Business and other management consultancy activities
Founded
11. april 2002
Share capital
DKK 500.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af en direktør.
Company purpose
Selskabets formål er at drive konsulentvirksomhed, at handle med kosttilskud og naturlægemidler, at drive import og eksport forretning samt at investere i, finansiere og administrere datter-, koncern- og andre selskaber.
Address
Korskildelund 4, 1.
Phone
+4556658887
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.566 | 444 | -21 | -51 | 66 | -31 | -240 | -241 | -173 | 246 | 331 | 335 | 408 | 173 |
| Staff expenses | -2.318 | -1.789 | -662 | -721 | -561 | -517 | -560 | -557 | -0 | -113 | -158 | -174 | -165 | -144 |
| EBITDA | -753 | -1.345 | -683 | -772 | -495 | -548 | -800 | -798 | -540 | 133 | 173 | 161 | 243 | 29 |
| Depreciation & amort. | -116 | -241 | -187 | -0 | -0 | -11 | 45 | 45 | -0 | 45 | -34 | -0 | -0 | -0 |
| EBIT | -868 | -1.586 | -870 | -772 | -495 | -559 | -844 | -843 | -540 | 88 | 139 | 161 | 243 | 29 |
| Net financials | 1.303 | 92 | 17 | 581 | -248 | -2.504 | 1.409 | -452 | 334 | 1.267 | -1.216 | -4.555 | 1.361 | 793 |
| Profit before tax | 435 | -1.494 | -853 | -191 | -743 | -3.063 | 564 | -1.295 | 6 | 1.355 | -1.077 | -4.394 | 1.604 | 821 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 435 | -1.494 | -853 | -191 | -743 | -3.063 | 564 | -1.295 | 6 | 1.355 | -1.077 | -4.394 | 1.604 | 821 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 17.131 | 17.562 | 26.808 | 26.928 | 27.007 | 24.030 | 20.083 | 16.592 | 16.268 | 16.652 | 14.866 | 9.525 | 10.684 | 9.160 |
| Equity | 8.243 | 6.749 | 5.895 | 5.704 | 4.961 | 1.437 | 2.001 | 706 | 712 | 2.067 | 990 | -3.404 | -1.800 | -979 |
| Long-term debt | 4.451 | 5.509 | 20.464 | 21.130 | 21.953 | 22.513 | 17.993 | 15.810 | 15.454 | 13.604 | 12.970 | 12.027 | 11.589 | 9.253 |
| Short-term debt | 3.918 | 5.304 | 449 | 95 | 93 | 80 | 88 | 76 | 102 | 981 | 906 | 902 | 896 | 885 |
| Total debt | 8.369 | 10.813 | 20.912 | 21.224 | 22.046 | 22.593 | 18.081 | 15.886 | 15.556 | 14.585 | 13.876 | 12.929 | 12.485 | 10.138 |
EBITDA margin
16.5%
This company
15.8%
Market median
+4% vs market
20122025
Equity ratio
-10.7%
This company
38.2%
Market median
-128% vs market
20122025
Return on equity
82143900.0%
This company
18.4%
Market median
+446434139% vs market
20122025
Net profit margin
475.5%
This company
8.1%
Market median
+5770% vs market
20122025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20122025
Debt / equity
10.36×
This company
0.62×
Market median
-1571% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CW Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
CA Management | Management | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2005 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 2002 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
VIPS HOLDING ApS | Company | 50.0% | 50.0% | 2017 |
MAW HOLDING ApS | Company | 50.0% | 50.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MAW HOLDING ApS
PHARMAVIE A/S Board members of PHARMAVIE A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carsten Wærn | Chief Executive Officer | 0 companies |
| Christel Arpalice Piron | Management | 0 companies |
| Espen Skeie | Board of Directors | 0 companies |
| Vibeke Wærn | Board of Directors | 0 companies |
| Margit Wærn | Chairman | 0 companies |
| Lars Henrik Jensen | Board of Directors | 0 companies |
| Flemming Wærn Johannessen | Board of Directors | 0 companies |
| Kren Erik Whittard Nielsen | Board of Directors | 0 companies |
| Ethel Wærn | Board of Directors | 0 companies |